Comparing Vascular Solutions (VASC) and WaferGen Bio-systems (WGBS)
Vascular Solutions (NASDAQ: VASC) and WaferGen Bio-systems (NASDAQ:WGBS) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, risk, valuation, profitabiliy, dividends, analyst recommendations and institutional ownership.
Valuation & Earnings
This table compares Vascular Solutions and WaferGen Bio-systems’ top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
WaferGen Bio-systems is trading at a lower price-to-earnings ratio than Vascular Solutions, indicating that it is currently the more affordable of the two stocks.
This table compares Vascular Solutions and WaferGen Bio-systems’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Insider & Institutional Ownership
80.2% of Vascular Solutions shares are owned by institutional investors. Comparatively, 49.8% of WaferGen Bio-systems shares are owned by institutional investors. 6.9% of Vascular Solutions shares are owned by company insiders. Comparatively, 5.8% of WaferGen Bio-systems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Risk & Volatility
Vascular Solutions has a beta of 0.98, suggesting that its stock price is 2% less volatile than the S&P 500. Comparatively, WaferGen Bio-systems has a beta of 1.29, suggesting that its stock price is 29% more volatile than the S&P 500.
This is a breakdown of recent recommendations and price targets for Vascular Solutions and WaferGen Bio-systems, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Vascular Solutions presently has a consensus price target of $51.75, suggesting a potential downside of 7.59%. Given Vascular Solutions’ higher probable upside, research analysts clearly believe Vascular Solutions is more favorable than WaferGen Bio-systems.
Vascular Solutions beats WaferGen Bio-systems on 7 of the 8 factors compared between the two stocks.
Vascular Solutions Company Profile
Vascular Solutions, Inc. is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world. Its products include GuideLiner catheters, Pronto catheters, Vein catheter reprocessing, Micro-introducer kits, Hemostatic patches, Radial access products, Langston catheters and D-Stat Flowable hemostat. The Company’s product portfolio includes a spectrum of over 90 products consisting of approximately 900 stock keeping units (SKUs) covering an array of blood clotting devices, extraction catheters, access catheters, guide extension catheters, micro-introducer kits, guidewires, snare and retrieval devices, a reprocessing service for radiofrequency catheters and a laser and procedure kits for the treatment of varicose veins.
WaferGen Bio-systems Company Profile
WaferGen Bio-systems, Inc. (WaferGen) is engaged in the development, manufacture and sale of genomic technology solutions for single-cell analysis (SCA) and clinical research. The Company focuses on marketing an open format genetic analysis system, the WaferGen SmartChip System. The Company’s ICELL8 Single-Cell System is a platform that can isolate a range of single cells and process specific cells for analysis, including Next Generation Sequencing (NGS). ICELL8 is based upon the Company’s SmartChip platform, which is also used for profiling and validating molecular biomarkers. The Company’s SmartChip is a micro-fabricated chip comprising a range of massively-parallel micro wells that are physically separated from each other. It offers SmartChip System Capabilities, SmartChip Single-Cell Isolation System, SmartChip Target Enrichment (TE) System and Apollo 324 Library Preparation.
Receive News & Ratings for Vascular Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vascular Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.